1 Anders Perner, Maurizio Cecconi, Maria Cronhjort, et al. Expert statement for the management of hypovolemia in sepsis[J]. Intensive Care Med, 2018, 44(6): 791-798.
2 Prescott HC, Angus DC. Postsepsis Morbidity[J]. JAMA, 2018, 319(1): 91.
3 Reinhart K, Daniels R, Kissoon N, et al. Recognizing Sepsis as a Global Health Priority-A WHO Resolution[J]. N Engl J Med, 2017, 377(5): 414-417.
4 唐轶珣, 祝益民. 脓毒症/脓毒性休克的循环管理 《拯救脓毒症运动:脓毒症与脓毒性休克治疗国际指南(2016版)》解读[J]. 实用休克杂志(中英文), 2017, 1(2): 120-122.
5 Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
6 Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Intensive Care Med, 2003, 29(4): 530-538.
7 Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
8 任成山, 刘绪钊, 郭中杰, 等. 全身炎症反应综合征1292例临床分析[J]. 中华内科杂志, 1999(1): 39-42.
9 Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis[J]. N Engl J Med, 2015, 372(17): 1629-1638.
10 张 宁, 周明明, 蒋正英, 等. 肺癌合并脓毒症mHLA-DR、CD39+ Treg及IL-10表达与预后相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(2): 169-174.
11 曹 钰, 柴艳芬, 邓 颖, 等. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 临床急诊杂志, 2018, 19(9): 567-588.
12 Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations(ICON)audit[J]. Lancet Respir Med, 2014, 2(5): 380-386.
13 Moreno R, Rhodes A, Piquilloud L, et al. The sequential organ failure assessment(SOFA)score: has the time come for an update[J]. Crit Care, 2023, 27(1): 15.
14 Xia Y, Zou L, Li D, et al. The ability of an improved qSOFA score to predict acute sepsis severity and prognosis among adult patients[J]. Medicine, 2020, 99(5): e18942.
15 Harris S. Sepsis-3: Syndromes and empiricism in the age of big data[J]. Am J Respir Crit Care Med, 2017, 195(7): 847-849.
16 王俊峰, 赵 亮, 王俊杰, 等. 脓毒血症肝损伤患者血清TBA、ALP水平与凝血功能特征观察[J]. 肝脏, 2022, 27(5): 593-595.
17 Vincent JL, Moreno R, Takala J, et al. The SOFA(Sepsis-related Organ Failure Assessment)score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7): 707-710.
18 Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11): 1181-1247.
19 Vincent JL, Bakker J. Blood lactate levels in sepsis: in 8 questions[J]. Curr Opin Crit Care, 2021, 27(3): 298-302.
20 Brodie D, Slutsky AS, Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review[J]. JAMA, 2019, 322(6): 557-568.
21 赵云峰, 徐志华, 巫梦娜, 等. 血清miR-133a在脓毒症并发ARDS中表达及预后的关系[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 38-41.
22 Schenck EJ, Hoffman KL, Cusick M, et al. Critical carE database for advanced research(CEDAR): An automated method to support intensive care units with electronic health record data[J]. J Biomed Inform, 2021, 118: 103789.
23 谢 云, 周志刚, 田 锐, 等. 重组人促血小板生成素改善脓毒症患者心肌损伤的临床研究[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(2): 213-217.
24 Reintam BA, Padar M, Mandul M, et al. Development of the Gastrointestinal Dysfunction Score(GIDS)for critically ill patients-A prospective multicenter observational study(iSOFA study)[J]. Clin Nutr, 2021, 40(8): 4932-4940.
25 Brinton DL, Ford DW, Martin RH, et al. Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation[J]. J Comp Eff Res, 2022, 11(1): 47-56.
26 任成山, 林 辉, 杨仕明. 循证医学应用中临床经验的重要性[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(3): 293-296.
27 Heming N, Azabou E, Cazaumayou X, et al. Sepsis in the critically ill patient: current and emerging management strategies[J]. Expert Rev Anti Infect Ther, 2021, 19(5): 635-647.
28 Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial[J]. Am J Respir Crit Care Med, 2019, 199(8): 980-986.
29 Wong HR, Lindsell CJ, Pettila V, et al. A multibiomarker-based outcome risk stratification model for adult septic shock*[J]. Crit Care Med, 2014, 42(4): 781-789.
30 John PD, Sarah MS, Patricia K, et al. Impact of reducing time-to-antibiotics on sepsis mortality, antibiotic use, and adverse events. Ann Am Thorac Soc, 2023, doi: 10.1513/AnnalsATS.202306-505OC